The magnitude of GLUT-4 reduction in subcutaneousadipocytes among these subjects is quantitatively similar to that observed inpatients with T2D or impaired glucose tolerance [280]. This evidence concerns the gene SLC2A4 and type 2 diabetes mellitus.